Today, the FDA approved the first gene therapy treatment for Duchenne Muscular Dystrophy. This groundbreaking treatment, developed here at Nationwide Children’s, is giving boys like Easton and Connor a future full of hope and possibilities. Watch their incredible stories.
Today, we approved the first gene therapy for the treatment of patients 4-5 years of age with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who do not have a pre-existing medical reason why they can't receive this therapy. https://t.co/AA02wAusjK
Thankful for family and friends today. Been a whirlwind of a few days with a long road ahead but blessed to know such great people who support me along the way!
@Anna_G_Downs Did you have any symptoms after any of your boosters and did you feel any different after this one? Scheduling mine soon and debating on if I need to do it before a day off so curious your experience 🧐